Diversified Consumer Services
Company Overview of The University of Melbourne
The University of Melbourne is a public university which has 22 discipline-specific faculties and graduate schools including Walter and Eliza Hall Institute of Medical Research, the Melbourne Institute of Applied Economic and Social Research and the Grattan Institute. It offers undergraduate and graduate degrees. The University of Melbourne was founded in 1853 and is based in Parkville, Australia.
1-100 Grattan Street
Parkville, VIC 3010
Founded in 1853
Key Executives for The University of Melbourne
Director of Melbourne Education Research Institute
Compensation as of Fiscal Year 2014.
The University of Melbourne Key Developments
Transgenomic Announces Research Agreement with University of Melbourne
Nov 12 14
Transgenomic Inc. has announced a research agreement with the University of Melbourne to conduct additional clinical validation studies of its Multiplexed ICE COLD-PCR, or MX-ICP, technology. MX-ICP is a high sensitivity DNA amplification technology that allows the simultaneous detection of multiple mutations in multiple genes from tumor samples or any liquid sample, such as blood or urine. MX-ICP can enable identification of known and unknown genetic mutations at limit of detection levels (LOD) of 0.01%, which is far more sensitive than the 5% LOD achieved by next-generation sequencing (NGS) alone and the 20% LOD achieved by Sanger sequencing. Previous studies have suggested that this ultra-high sensitivity makes it possible to analyze DNA shed by tumors into the patient's circulation, eliminating the need to use tissue from invasive and costly tumor biopsies for the DNA analyses needed to serially monitor disease progression and therapeutic benefit in personalized cancer therapy.
Melbourne University to Cut 540 Jobs
Jun 5 14
University of Melbourne is cutting 540 jobs. The National Tertiary Education Union workers were told of the job losses on June 5, 2014.
Sanofi Pasteur Partners with Melbourne University on Immunology, Infectious Disease Research
Jan 23 14
Sanofi Pasteur has signed an agreement with the University of Melbourne (UoM) to co-fund proof-of-concept studies in relation to development of immune-boosting substances and vaccines against infectious diseases. According to a UoM press release, the studies will be carried out on technology developed by the university, with Sanofi Pasteur supporting the research and gaining right of first refusal to acquire exclusive worldwide licence to successful products.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries